How to Buy Lemaitre Vascular Stock
Lemaitre Vascular Inc
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide.
Lemaitre Vascular stock last closed at $96.89, up 0.6% from the previous day, and has increased 68.62% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.55 percentage points. Lemaitre Vascular stock is currently +72.89% from its 52-week low of $56.04, and -11.58% from its 52-week high of $109.58.
There are currently 22.48M shares of LMAT outstanding. The market value of LMAT is $2.18B. In the past 24 hours, 139,829 LMAT shares were traded.
How to Buy Lemaitre Vascular Stock
Wondering how to invest in Lemaitre Vascular stock? Here's how.
- Choose where to buy Lemaitre Vascular stock: You need to pick an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you figure out where to buy Lemaitre Vascular stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your investment account: Select your payment method and add your information.
- Research Lemaitre Vascular stock: The Lemaitre Vascular ticker symbol is LMAT. Is Lemaitre Vascular stock a good investment? Should you buy shares of LMAT? How do LMAT's underlying business fundamentals look? Do top analysts think Lemaitre Vascular is a good buy? Why has LMAT's stock price moved recently? (Hint: Our stock research website can help you figure out if LMAT is a good stock to buy).
- Execute your LMAT purchase: Decide if you will purchase LMAT shares at the current market price or use a limit order to buy LMAT stock at a particular price.
- Watch your LMAT investment: Create a watchlist to the latest updates on your position in Lemaitre Vascular shares.
Step 1: Choose where to buy Lemaitre Vascular stock
You need an online brokerage account to access the NASDAQ market and buy LMAT stock.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal details so you can invest in LMAT stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to open your new brokerage account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have finished signing up on the best free stock trading app, you can securely and quickly fund your account:
Check out the walkthrough below if you need help transferring money into your new investment account.
Step 4: Research Lemaitre Vascular stock
After you have selected the best place to buy Lemaitre Vascular stock, it's very important to evaluate their stock before you buy, so you can understand the risk as well as the upside.
Lemaitre Vascular stock data
Lemaitre Vascular Due Diligence Score
WallStreetZen was created to help average investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on LMAT's stock page.
Is LMAT stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge LMAT's true value.
Using relative valuations ratios:
- LMAT may be overvalued based on its P/E ratio of 52.09x, relative to Medical Instruments & Supplies industry P/E ratio of 38.4x
- LMAT may be overvalued based on its P/B ratio of 6.58x, relative to Medical Instruments & Supplies industry P/B ratio of 4.19x
- LMAT may be overvalued based on its PEG ratio of 4.38x
You can access more valuation analysis on LMAT's stock here.
LMAT Financial Health Overview
Positive Health Checks:
- Total LMAT debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the LMAT balance sheet.
- LMAT's operating cash flow of $39.69M allows it to safely service it's debt of $18.33M.
- LMAT has a low debt to equity ratio of 0.14.
- LMAT profit margin has gone up from 14.7% to 19.4% in the past year.
- There are more short-term assets than long-term liabilities on the LMAT balance sheet.
- LMAT earnings of $54.17M is not enough to cover its interest payments.
Is Lemaitre Vascular stock a Buy, Hold, or Sell, according to analysts?
Out of 4 sell side analysts who monitor LMAT, the consensus analyst rating on LMAT is a Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Lemaitre Vascular stock forecast page.
LMAT Technicals
How is LMAT performing as a company?
Last year, LMAT earnings were $41.32M. During the past 5 year, LMAT's earnings have grown by 13.67% per year. This was slower than the Medical Instruments & Supplies industry average of 17.54%.
Last year, LMAT revenue was $213.03M. Over the past 5 year, LMAT's revenue has gone up by 13.03% per year. This was faster than the Medical Instruments & Supplies industry average of 10.36%.
You can research LMAT's earnings and revenue performance here.
Latest Insiders Trades at LMAT
In the past 12 months, executives and large shareholders at LMAT have sold more shares than they have bought.
Trent G. Kamke, Senior V. P. Operations of LMAT, was the latest LMAT insider to sell. They sold $5,066.60 worth of LMAT shares on Dec 20, 2024.
Get more info about who owns LMAT shares here.
Does LMAT provide a stable income stream?
Lemaitre Vascular pays a dividend of 0.66%, compared to the Medical Instruments & Supplies industry's average dividend yield of 1.26%. If you owned $1,000 worth of LMAT stock, you would have received $6.61 last year.
Lemaitre Vascular dividend payments have consistently grown over the past decade and have remained stable.
Dig into more analysis about Lemaitre Vascular dividend yield and history here.
What others are saying about LMAT
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your LMAT purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.
Hit the Open Trade button and eToro will execute the order.
If you need more info about investing in stocks on eToro, click the helpful video below:
Step 6: Watch your LMAT investment
Now that you own some LMAT stock, you'll want to stay up-to-date on your investment.
Put LMAT on a watchlist to get notified of important updates regarding your LMAT stock.
LMAT Feed
How to Buy Stock in Lemaitre Vascular
To reiterate, here are the 6 steps for buying Lemaitre Vascular stock:
- Choose where to buy Lemaitre Vascular stock
- Sign up for your brokerage account
- Fund your investment account
- Research Lemaitre Vascular stock
- Execute your LMAT purchase
- Watch your LMAT investment
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your new investment in Lemaitre Vascular, click the button below.
More Articles You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.